Judith A. Smith - Concepedia

Author

Judith A. Smith

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

David Gillis, J A Smith, J Smith, J. A. SMITH, J. A. Smith, J. Smith, J.A. Smith, J.acqueline I. Smith, JUDITH A SMITH, JUDITH A. SMITH

157

Publications

3.9K

Citations

H-Index

129

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center The University of Texas Health Science Center at Houston University of Pennsylvania Memorial Hermann University of Liverpool

About

Judith A. Smith is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, pharmacology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	35	1.7K
2	Health Sciences	5	5	209
3	Public Health	4	4	98
4	Natural Sciences	3	3	82
5	Engineering	1	1	64

Judith A. Smith

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
Rankings and symptom assessments of side effects from chemotherapy: insights from experienced patients with ovarian cancer Charlotte C. Sun, Diane C. Bodurka, C. B. Weaver, Supportive Care in Cancer OncologyExperienced PatientsCancer ManagementGynecologySide Effects	2004	294
An Assessment of the Utilization of Complementary and Alternative Medication in Women With Gynecologic or Breast Malignancies Marisa A. Navo, Julie Phan, Christy Vaughan, Journal of Clinical Oncology	2004	195
Nonmitogenic Anti-CD3 Monoclonal Antibodies Deliver a Partial T Cell Receptor Signal and Induce Clonal Anergy Judith A. Smith, J. Yun Tso, Marcus R. Clark, The Journal of Experimental Medicine	1997	189
Characterization of olanzapine-induced weight gain in rats Andrew J. Goudie, Judith A. Smith, Jason C. G. Halford Journal of Psychopharmacology	2002	108
Inhibition of export of fibroblast growth factor-2 (FGF-2) from the prostate cancer cell lines PC3 and DU145 by anvirzel and its cardiac glycoside component, oleandrin11Abbreviations: PARP, poly(ADP-ribose) polymerase; NF-κB, nuclear factor-κB; FGF-2, fibroblast growth factor-2; ER, endoplasmic reticulum; and MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide. Judith A. Smith, Timothy Madden, Mary Vijjeswarapu, Biochemical Pharmacology Tumor BiologyFibroblast Growth Factor-2Medicine-2,5-Diphenyltetrazolium BromideCancer Cell Biology	2001	103
An anti-murine CD3 monoclonal antibody with a low affinity for Fc γ receptors suppresses transplantation responses while minimizing acute toxicity and immunogenicity Maria‐Luisa Alegre, J. Yun Tso, Husain Sattar, The Journal of Immunology	1995	101
Partial TCR Signals Delivered by FcR-Nonbinding Anti-CD3 Monoclonal Antibodies Differentially Regulate Individual Th Subsets Judith A. Smith, Qizhi Tang, Jeffrey A. Bluestone The Journal of Immunology T-regulatory CellImmunologyImmune RegulationImmunologic MechanismAntigen Processing	1998	100
Evaluation of the incidence of carboplatin hypersensitivity reactions in cancer patients Marisa A. Navo, Anuradha Kunthur, Martina L. Badell, Gynecologic Oncology OncologyAllergyMedicineCarboplatin Hypersensitivity ReactionsCancer Patients	2006	96
Genistein differentially inhibits postreceptor effects of insulin in rat adipocytes without inhibiting the insulin receptor kinase. Andrew S. Abler, Judith A. Smith, Paul A. Randazzo, Journal of Biological Chemistry Insulin LevelsAdipocytes GenisteinInsulin SignalingObesityMetabolic Syndrome	1992	94
Six- and Twelve-Month Follow-up of Sexually Abused Girls Anthony P. Mannarino, Judith A. Cohen, Judith A. Smith, Journal of Interpersonal Violence Twelve-month Follow-upMental HealthChild Mental HealthPsychologySocial Sciences	1991	93

Page 1